Head of Immunology Víctor Cervera-Carrascón received Merit Award for ESMO Immuno-Oncology Congress 2019. Víctor will present his abstract “Increasing responses to T-cell therapies in solid tumours by the use of an engineered adenovirus coding for TNFa and IL-2” at the congress in Geneva in December.
Latest News
Upcoming Events
Please contact our business development team to meet us at the following events:
27-30th October 2024
16th Annual International Oncolytic Virotherapy Conference
Rotterdam, Netherlands
4-6th November 2024
BIO-Europe
Stockholm, Sweden
20-21st November 2024
SLUSH
Helsinki, Finland
11-13th December 2024
ESMO Immuno-Oncology Congress
Geneva, Switzerland
13-15th January 2025
Biotech Showcase
San Francisco (CA), USA